Emerging Trends in Regulatory Strategies for Oncology & Neurovascular Trials
Biotech startups navigating oncology and neurovascular trials face complex regulatory shifts. Discover how integrating real-world evidence and adaptive designs streamline timelines and mitigate risks in 2024-2025 studies.
Robert Maxwell
Jul 11, 2025
stroke trial regulations
breast cancer compliance
adaptive design oversight
real-world evidence FDA
